Professional Documents
Culture Documents
Global 2020 2nd Compressed
Global 2020 2nd Compressed
A A R
Presented to
C O N S U LT I
Executive Summary - The PaaS Strategy A
Q
A R
USE THE CIRCULAR ECONOMY AS A DRIVER TO REACH MORE PATIENTS BY 2050 WHILE STRIVING FOR ZERO ENVIRONMENTAL
IMPACT
1
Awareness AWARENESS CAMPAIGNS Capture additional
Intervene early in the customer journey through
How can Novo Nordisk increase diabetes
awareness and encourage more Awareness Campaigns launched in collaboration with 481K
individuals to get tested? The American Diabetes Association across high-risk new customers
communities in the USA.
2
Patient Support LIFESTYLE APPLICATION | NovoAPP
Sale Increase
Launch a lifestyle application for all patients using a
How can Novo Nordisk support their
patients once they are diagnosed and
Novo Nordisk device, tackling all 5 Core Patient 4,722 M DKK
have purchased their device? Needs and offering a holistic approach to living with
(6.4% CAGR 2025)
the disease.
3
Circular Economy GIVE DEVICES AS SECOND LIFE Market
Saving
Transform the take-make-waste model into a circular Share
How can Novo Nordisk decrease their
environmental impact in their value
economy by giving devices a second life via a more Increase by 4K tons
chain? frequent use of the Autoclave and acquisition of of plastic yearly
Terragon’s MAGS technology in the value chain. 3%
NOVO NORDISK Executive Insights Strategy Impact Summary 2
Key Internal Dimensions & Drivers A A R
Q
Novo Nordisk current standing with the task at hand
Key Players
in the
Supply Factory Doctors Patients Transpor Production
t
Chain
2020 2025
2030
Given the American markets’ large size and steady long-term growth rate, we are confident that continuously investing in
patient well-being as well as piloting circular economy initiatives in this region will enable Novo Nordisk to increase their
outreach while diminishing environmental impact, setting the stage to scale projects globally.
NOVO NORDISK Executive Insights Strategy Impact Summary 4
Competing on Customer Journey & Product Experience A A R
Q
Focusing on areas of the supply chain where Novo Nordisk can take leadership
in reducing environmental impact
Innovative Produce Pack &
R&D API
Using 6 key
Dispatch
Intentionally eco- facilities produces Delivery through Waste
conscious product insulin in aseptic eco-conscious
design and maintain conditions alternatives while At every step of the
high speed to patent maintaining fresh supply chain, waste
product is produced and dealt
2 4 6 with in different
ways.
However, Novo
1 3 5 Nordisk itself only
accounts for 10% of
its waste. Moving
Plan and source to a circular
Distribute to
through 40,000 Final assembly in economy will
customers through
suppliers as market accordance to local require Novo
local affiliates,
demand varies laws and regulations Nordisk to take
reaching patients
Novo Nordisk’s Level of ownership of its
Control
Plan & Source Assembly Patients waste across the
High Control
supply chain.
Medium Control
While Novo has achieved great environmental sustainability upstream in its supply chain, they needs to make their
Low Control
customer journey more sustainable through the circular economy
NOVO NORDISK Executive Insights Strategy Impact Summary 5
Complete Overview of the Customer Journey A A R
Q
The PaaS Strategy increases the number of touch points with the patient
INTRODUCTION TO NovoPEN & Needles & Cartridges are
LIFE DOESN’T STOP NovoAPP 2
AT DIABETES 1 sent back to the 3rd party
distributor. Once arrived,
CAMPAIGN Sydney’s receives her NovoPEN, a they will both go through
She notices a striking advertisement funny looking tool she will have to their individual circular
on diabetes on her bus ride back inject in her side once a day. Her economy journey.
home from work, highlighting how pharmacist informs her about the
you may not know you’re diabetic… complementary NovoAPP – a
It encourages her to visit her doctor. lifestyle app for a lifestyle disease.
Of the 30.3M
Americans with
diabetes, 7.2M remain
undiagnosed which
represents 24% of
affected individuals.
Case study
Prostate Cancer in Canada
BALANCING LIFE & DISEASE A QR code on promotional pamphlets will encourage patients
Equip patients with tools to fight stigma, gain to download the NovoAPP after purchase of their device at
self-confidence and openly discuss
3 their local pharmacy.
mental health through educational blog
posts
SELF-CARE CAPABILITIES
Recipe of the day
Simple nutritional & fitness plans educating FACILITATE PRESCRIPTION REFILLS
4
patients on healthy lifestyle tips that will
Enable seamless patient refill experience with an in-app order
help
functionality, connected to patient's pharmacy of choice.
shape their new normal
REDUCE COMPLEXITY Let’s make zero environmental
How-To videos and step-by-step tutorials 5 impact, together
ENVIRONMENTAL AWARENESS
THROUGH
The NovoAPPGAMIFICATION
will incentivize patients to return their disposable
HI, SYDNEY! 115 HI, SYDNEY! 115
FUN GREEN FACTS points FUN GREEN FACTS points device’s pieces, through push notifications and gamification,
to their pharmacy in order to reduce their environmental
impact.
This month, You have This month, you have
saved 19 PLASTIC BAGS! saved enough energy to Once returned, the patients notify the APP and are awarded
cook a PIZZA for an HOUR!
Greener points to their profile.
Patients can compare their Greener score with other community
members.
Everyday
The NovoAPP Benchmarks Ripple Effect
community has saved Help patients measure the
enough energy to Novo Nordisk will be at the root
The NovoAPP community positive impact they are of greater change by nurturing an
has saved +644M PLASTIC POWER +830 HOMES having on the environment
BAGS together! for a year! eco-conscious mind-set within
in ways that they can their patient community.
truly measure, not vague
statistics.
REUSED REUSED
The pen is currently the only part of the We will continue to invest in innovative and
treatment which can be reused by the patients, long-lasting pens while educating
they generally keep it for numerous years customers
SINGLE-USE MULTI-USE
After their use, the cartridges, depending on At the heart of the waste problem,
where it is used, can be thrown in the recycling cartridges are going to be shipped back to
bin, however, it means that we would be relying the filling centers, sterilized, filled-again
on local authorities and sent again to the customers
STEP THREE
Yellow and blue safety
bags, filled with used
products, are brought back
to the pharmacy STEP FIVE STEP SIX STEP SEVEN
Cartridges are shipped back Cartridges1 go through Newly filled
to one of the 6 key an autoclave to be cartridges are
production facilities in BR, sanitized and then packaged, sealed
FR, US, DK, CH refilled and shipped
1 Plastic recommendation for reusable cartridges is Polypropylene (PP) or Polypropylene copolymer (PCO)
TERRAGON’S EXPERTISE
Terragon Environmental Technologies Inc. is the unique, Montreal-based
STEP EIGHT
Thermal energy allows firm, that invented the Micro Auto Gasification System (MAGS). Without
the production plant to any preprocessing, the MAGS unit is able to break down waste, including
be self-sufficient
medical waste (ex: sharps). The only byproduct of the process is non-
SYRINGES
STRATEGIC ACQUISITION OF
TERRAGON
CAD 11M
Taking ownership of bio-medical product waste
Recognizing the waste produced throughout the lifecycle of Annual Sales
their products X
3.58x
CARTRIDGES
$10.0
Operational Expenses (2020) Capital Expenditures (2020)
-
Admin. Other PPE - MAGS 2019a 2020e
8% PPE -
1% Autoclave
15%
R&D
Awareness 3% WACC = 8.4% Net Present Value = 111,065M DKK1
2,856M 34% 380M
20% DKK DKK App
Operatin Current value per Project value per New implied value
g capex intangibl
Sales and share = share = per share = 473
81% e value
Dis. 1% 435 DKK 39 DKK DKK
37%
By implementing the PaaS strategy Novo Nordisk will be able to create 111,065M DKK in value while boosting its per share
price by 39 DKK and growing its EPS by 7.5% annually till 2025
x
NOVO NORDISK Executive Insights Strategy Impact Summary 14
The PaaS Strategy Will be Implemented Throughout
A A R
the Decade to be Ready For A Scale Up Q
PaaS 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
1. Awareness
3 Purchase of the
autoclaves
4 Develop shipping-back
4. Future Considerations
logistics
51 Scale up current initiatives
Finalize and fully
2 Further penetrate African
implement
and South East Asian Market
Our PaaS Strategy enables Novo Nordisk to use a circular economy as a driver to reach more patients by
2050 while striving for zero environmental impact, aligned with 5 SDGs